PCN30 A COST—UTILITY ANALYSIS MODEL FOR THE SECOND LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN MEXICO
Abstract
Authors
I Contreras-Hernandez J Mould-Quevedo G Salinas-Escudero J Tapia-Valencia G Davila-Loaiza J Garduño-Espinosa